Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Tables)

v3.7.0.1
Summary of Significant Accounting Policies (Tables)
 6 Months Ended
Jun. 30, 2017
Summary of Significant Accounting Policies  
Schedule operating expenses for comparative periods as previously reported and as presented after the reclassifications

 

The operating expenses for comparative periods as previously reported and as presented after the reclassifications are as follows (in thousands):

 

 

 

Three months ended
June 30, 2016

 

Six months ended
June 30, 2016

 

 

 

As previously
reported

 

After
reclassification

 

As previously
reported

 

After
reclassification

 

Research and development

 

$
16,219

 

$
16,856

 

$
30,107

 

$
31,332

 

General and administrative

 
6,809

 
6,172

 
12,664

 
11,439

 

 

 

 

 

 

 

 

 

 

 

Total operating expenses

 

$
23,028

 

$
23,028

 

$
42,771

 

$
42,771

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Schedule of the reconciliation of cash, cash equivalents, and restricted cash

 

The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the balance sheet that sum to the total of the same such amounts shown in the statement of cash flows (in thousands).

 

 

 

June 30,
2017

 

December 31,
2016

 

Cash and cash equivalents

 

$
121,998

 

$
158,779

 

Restricted cash

 
4,156

 
4,017

 

 

 

 

 

 

 

Total cash, cash equivalents, and restricted cash shown in the statement of cash flows

 

$
126,154

 

$
162,796

 

 

 

 

 

 

 

 

 

 

Schedule of investments in available-for-sale debt securities categorized as cash equivalents or marketable securities

 

At June 30, 2017, the Company has the following investments in available-for-sale debt securities, which are categorized as cash equivalents or marketable securities – available-for-sale debt securities on the balance sheet depending on their maturity at acquisition (in thousands):

 

 

 

Maturity

 

Amortized
cost

 

Gross
Unrealized
Gains

 

Gross
Unrealized
Losses

 

Foreign
currency
translation
adjustment

 

Aggregate
Estimated
Fair Value

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

 

Corporate debt securities

 

Less than 3 months

 

$
2,052

 

$

 

 

$
(63

)

$
62

 

$
2,051

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$
2,052

 

$

—

 

$
(63

)

$
62

 

$
2,051

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Marketable securities – available-for-sale debt securities:

 

 

 

 

 

 

 

 

 

 

 

 

 

Corporate debt securities

 

3 months to 1 year

 

$
73,601

 

$

 

 

$
(1,132

)

$
1,068

 

$
73,537

 

Corporate debt securities

 

1 to 2 years

 
6,495

 

 

 
(101

)
92

 
6,486

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$
80,096

 

$

—

 

$
(1,233

)

$
1,160

 

$
80,023